Sign inGet started

KLRA

Kailera Therapeutics, Inc.CIK 2096997 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19

AI insights for KLRA PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for KLRA
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Nicholson NurChief Technology Officer2$0$02026-09-07
Tregoning KathleenSee Remarks1$0$02026-07-06
Renaud Ronald C JRCEO & President4$0$02026-06-09
BCPE Perseus Investor, LP10% Owner3$134.38M$02026-04-20
Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% Owner4$0$02026-04-20
BCLS Fund IV Investments GP, LLC10% Owner5$25.00M$02026-04-20
Kaplan Andrew T.Director, 10% Owner4$134.38M$02026-04-20
Koppel AdamDirector, 10% Owner6$25.00M$02026-04-20
RTW INVESTMENTS, LP10% Owner4$8.00M$02026-04-20
Wasserman Scott M.Chief Medical Officer2$0$02026-04-16
Coleman Jamie BethChief Commercial Officer2$0$02026-04-16
Akamine ScottChief Legal Officer2$0$02026-04-16
Hite ChristopherDirector1$0$02026-04-16
Clyburn FrankDirector1$0$02026-04-16
Cloghessy PaulaChief People Officer2$0$02026-04-16
Burgess Paul D.See Remarks2$0$02026-04-16
Pagan Douglas W.Chief Financial Officer2$0$02026-04-16
MACKAY MARTINDirector1$0$02026-04-16
MILLIGAN JOHN FDirector1$0$02026-04-16

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Nicholson NurChief Technology Officer A Award deriv2026-09-072026-09-09220,000— $0220,000SEC↗
Nicholson NurChief Technology Officer A Award deriv2026-09-072026-09-09220,000— $0220,000SEC↗
Tregoning KathleenSee Remarks A Award deriv2026-07-062026-07-08175,000— $0175,000SEC↗
Renaud Ronald C JRCEO & President M Exercise deriv2026-06-092026-06-1138,094— $0817,826SEC↗
Renaud Ronald C JRCEO & President M Exercise2026-06-092026-06-1138,094$5.25 $200.0K38,094SEC↗
Kaplan Andrew T.Director, 10% Owner C Conversion deriv2026-04-202026-04-2017,857,143— $00SEC↗
BCLS Fund IV Investments GP, L10% Owner C Conversion deriv2026-04-202026-04-204,145,768— $00SEC↗
BCLS Fund IV Investments GP, L10% Owner C Conversion deriv2026-04-202026-04-2016,875,000— $00SEC↗
Koppel AdamDirector, 10% Owner C Conversion deriv2026-04-202026-04-2016,875,000— $00SEC↗
Koppel AdamDirector, 10% Owner C Conversion deriv2026-04-202026-04-204,145,768— $00SEC↗
BCPE Perseus Investor, LP10% Owner C Conversion deriv2026-04-202026-04-2017,857,143— $00SEC↗
Jiangsu Hengrui Pharmaceutical10% Owner C Conversion deriv2026-04-202026-04-22708,814— $00SEC↗
Jiangsu Hengrui Pharmaceutical10% Owner C Conversion deriv2026-04-202026-04-224,968,789— $00SEC↗
RTW INVESTMENTS, LP10% Owner C Conversion deriv2026-04-202026-04-222,026,820— $00SEC↗
RTW INVESTMENTS, LP10% Owner C Conversion deriv2026-04-202026-04-228,250,000— $00SEC↗
Kaplan Andrew T.Director, 10% Owner C Conversion2026-04-202026-04-2017,857,143— $017,857,143SEC↗
Kaplan Andrew T.Director, 10% Owner P Buy2026-04-202026-04-208,398,438$16.00 $134.38M26,255,581SEC↗
BCLS Fund IV Investments GP, L10% Owner C Conversion2026-04-202026-04-204,145,768— $021,020,768SEC↗
BCLS Fund IV Investments GP, L10% Owner P Buy2026-04-202026-04-201,562,500$16.00 $25.00M22,583,268SEC↗
BCLS Fund IV Investments GP, L10% Owner C Conversion2026-04-202026-04-2016,875,000— $016,875,000SEC↗
Koppel AdamDirector, 10% Owner C Conversion2026-04-202026-04-2016,875,000— $016,875,000SEC↗
Koppel AdamDirector, 10% Owner P Buy2026-04-202026-04-201,562,500$16.00 $25.00M22,583,268SEC↗
Koppel AdamDirector, 10% Owner C Conversion2026-04-202026-04-204,145,768— $021,020,768SEC↗
BCPE Perseus Investor, LP10% Owner P Buy2026-04-202026-04-208,398,438$16.00 $134.38M26,255,581SEC↗
BCPE Perseus Investor, LP10% Owner C Conversion2026-04-202026-04-2017,857,143— $017,857,143SEC↗
Jiangsu Hengrui Pharmaceutical10% Owner C Conversion2026-04-202026-04-229,477,719— $09,477,719SEC↗
Jiangsu Hengrui Pharmaceutical10% Owner C Conversion2026-04-202026-04-222,034,133— $02,034,133SEC↗
RTW INVESTMENTS, LP10% Owner P Buy2026-04-202026-04-22500,000$16.00 $8.00M10,776,820SEC↗
RTW INVESTMENTS, LP10% Owner C Conversion2026-04-202026-04-2210,276,820— $010,276,820SEC↗
Pagan Douglas W.Chief Financial Officer A Award deriv2026-04-162026-04-20100,000— $0100,000SEC↗
Pagan Douglas W.Chief Financial Officer A Award deriv2026-04-162026-04-20100,000— $0100,000SEC↗
Clyburn FrankDirector A Award deriv2026-04-162026-04-2038,300— $038,300SEC↗
Hite ChristopherDirector A Award deriv2026-04-162026-04-2038,300— $038,300SEC↗
Wasserman Scott M.Chief Medical Officer A Award deriv2026-04-162026-04-20100,000— $0100,000SEC↗
Wasserman Scott M.Chief Medical Officer A Award deriv2026-04-162026-04-20100,000— $0100,000SEC↗
MACKAY MARTINDirector A Award deriv2026-04-162026-04-2038,300— $038,300SEC↗
Coleman Jamie BethChief Commercial Officer A Award deriv2026-04-162026-04-2075,000— $075,000SEC↗
Coleman Jamie BethChief Commercial Officer A Award deriv2026-04-162026-04-2075,000— $075,000SEC↗
MILLIGAN JOHN FDirector A Award deriv2026-04-162026-04-2038,300— $038,300SEC↗
Burgess Paul D.See Remarks A Award deriv2026-04-162026-04-20100,000— $0100,000SEC↗
Burgess Paul D.See Remarks A Award deriv2026-04-162026-04-20100,000— $0100,000SEC↗
Renaud Ronald C JRCEO & President A Award deriv2026-04-162026-04-20300,000— $0300,000SEC↗
Renaud Ronald C JRCEO & President A Award deriv2026-04-162026-04-20300,000— $0300,000SEC↗
Akamine ScottChief Legal Officer A Award deriv2026-04-162026-04-2060,000— $060,000SEC↗
Akamine ScottChief Legal Officer A Award deriv2026-04-162026-04-2060,000— $060,000SEC↗
Cloghessy PaulaChief People Officer A Award deriv2026-04-162026-04-2060,000— $060,000SEC↗
Cloghessy PaulaChief People Officer A Award deriv2026-04-162026-04-2060,000— $060,000SEC↗
Kaplan Andrew T.Director, 10% Owner A Award deriv2026-04-162026-04-2038,300— $038,300SEC↗
Koppel AdamDirector, 10% Owner A Award deriv2026-04-162026-04-2038,300— $038,300SEC↗